Despite extensive research, regulatory approval for cardiovascular nanomedicines remains limited. Most clinically approved nanomedicines are in oncology or rare genetic conditions, highlighting the gap between innovation and routine cardiac care (Ventola, 2017; Della Pepa et al., 2021). This evolving landscape underscores the need for nurses to understand emerging therapies and their implications for patient monitoring and safety. Nurses play a central role in patient care by monitoring responses to nano-enabled interventions, recognizing subtle or delayed physiological effects, and ensuring treatments are safe and ethically delivered (Huertas et al., 2024; WHO, 2023). They also support patients by translating complex scientific information into understandable guidance, promoting informed decision-making, adherence, and trust in care (Ventola, 2017; Huertas et al., 2024). For nursing education, integrating nanotechnology into curricula is essential. Teaching mechanisms of action, safety considerations, ethical reasoning, and interprofessional collaboration prepares nurses to provide evidence-based care, respond to clinical uncertainties, and participate in research translation and innovation in cardiovascular healthcare (Huertas et al., 2024; WHO, 2023).
FOR NURSING EDUCATION, INTEGRATING NANOTECHNOLOGY INTO CURRICULA IS ESSENTIAL.
11
Made with FlippingBook. PDF to flipbook with ease